IDO1 and depressive symptom measurement: The diverse findings on KYN metabolic abnormalities in depression suggest a possible mechanism by which the peripheral IFN activates IDO in the CNS, leading to increased QUIN levels in the brain and the subsequent activation of NMDA receptors.